Ranking Antimicrobial Peptides by Their Effectiveness Against Whooping Cough Bacteria
Cecropin B was the most potent antimicrobial peptide against Bordetella pertussis, followed by cecropin A, with a clear potency ranking established across multiple peptide families.
Quick Facts
What This Study Found
Cecropin B was the most potent antimicrobial peptide against B. pertussis, with cecropins generally outperforming magainins, defensins, and protamine.
Key Numbers
How They Did This
In vitro susceptibility testing of B. pertussis strains against multiple antimicrobial peptides, determining the concentration required to inhibit or kill 50% of the bacterial population (MIC50/MBC50).
Why This Research Matters
Whooping cough remains a significant public health concern. Identifying effective antimicrobial peptides against B. pertussis could lead to novel treatment approaches, especially as antibiotic resistance grows.
The Bigger Picture
As antibiotic resistance becomes a growing global threat, antimicrobial peptides offer a fundamentally different approach to fighting bacterial infections. This study maps which peptide families are most effective against a clinically important pathogen.
What This Study Doesn't Tell Us
In vitro study only. Effectiveness in a test tube doesn't guarantee clinical efficacy. Bioavailability, toxicity, and stability of these peptides in the human body were not assessed.
Questions This Raises
- ?Could cecropin-based treatments be developed for antibiotic-resistant pertussis?
- ?What structural features make cecropins particularly effective against this pathogen?
Trust & Context
- Key Stat:
- Cecropin B most potent Cecropin B outperformed all other tested antimicrobial peptides against B. pertussis strains
- Evidence Grade:
- Moderate in vitro evidence with systematic comparison of multiple peptides. No in vivo or clinical data.
- Study Age:
- Published in 1996, this study contributed to the early characterization of antimicrobial peptide activity against respiratory pathogens.
- Original Title:
- Susceptibilities of Bordetella pertussis strains to antimicrobial peptides.
- Published In:
- Antimicrobial agents and chemotherapy, 40(4), 1041-3 (1996)
- Authors:
- Fernandez, R C, Weiss, A A
- Database ID:
- RPEP-00360
Evidence Hierarchy
Frequently Asked Questions
What are antimicrobial peptides?
Antimicrobial peptides (AMPs) are small proteins produced by many organisms as natural antibiotics. They typically kill bacteria by disrupting their cell membranes, making it harder for bacteria to develop resistance compared to conventional antibiotics.
Why is B. pertussis important?
Bordetella pertussis causes whooping cough (pertussis), a highly contagious respiratory disease that can be serious or fatal in infants. Despite vaccination, outbreaks still occur and antibiotic resistance is a growing concern.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00360APA
Fernandez, R C; Weiss, A A. (1996). Susceptibilities of Bordetella pertussis strains to antimicrobial peptides.. Antimicrobial agents and chemotherapy, 40(4), 1041-3.
MLA
Fernandez, R C, et al. "Susceptibilities of Bordetella pertussis strains to antimicrobial peptides.." Antimicrobial agents and chemotherapy, 1996.
RethinkPeptides
RethinkPeptides Research Database. "Susceptibilities of Bordetella pertussis strains to antimicr..." RPEP-00360. Retrieved from https://rethinkpeptides.com/research/fernandez-1996-susceptibilities-of-bordetella-pertussis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.